Clinical Trial Update: Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 [Phase 2]

View source ↗

Summary

Phase 2 multiple-dose trial of IXT-m200 in individuals with methamphetamine use disorder was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Abuse
• Methamphetamine Use Disorder

Drugs mentioned

• IXT-m200

Snippet

Sponsor: InterveXion Therapeutics, LLC | Conditions: Methamphetamine-dependence, Methamphetamine Abuse | Phase 2 | Status: TERMINATED | Results posted: 2024-10-04